159 related articles for article (PubMed ID: 27381449)
21. Pax9 is essential for granulopoiesis but dispensable for erythropoiesis in zebrafish.
Pak B; Schmitt CE; Oh S; Kim JD; Choi W; Han O; Kim M; Kim MJ; Ham HJ; Kim S; Huh TL; Kim JI; Jin SW
Biochem Biophys Res Commun; 2021 Jan; 534():359-366. PubMed ID: 33256983
[TBL] [Abstract][Full Text] [Related]
22. Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes.
Chu VT; Weber T; Graf R; Sommermann T; Petsch K; Sack U; Volchkov P; Rajewsky K; Kühn R
BMC Biotechnol; 2016 Jan; 16():4. PubMed ID: 26772810
[TBL] [Abstract][Full Text] [Related]
23. A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme.
Inoue S; Inoue M; Fujimura S; Nishinakamura R
Genesis; 2010 Mar; 48(3):207-12. PubMed ID: 20127799
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the
Lesaffer B; Verboven E; Van Huffel L; Moya IM; van Grunsven LA; Leclercq IA; Lemaigre FP; Halder G
Cells; 2019 Apr; 8(4):. PubMed ID: 31027317
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory neuron-specific Cre-dependent red fluorescent labeling using VGAT BAC-based transgenic mouse lines with identified transgene integration sites.
Kaneko R; Takatsuru Y; Morita A; Amano I; Haijima A; Imayoshi I; Tamamaki N; Koibuchi N; Watanabe M; Yanagawa Y
J Comp Neurol; 2018 Feb; 526(3):373-396. PubMed ID: 29063602
[TBL] [Abstract][Full Text] [Related]
26. Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele.
Korecki AJ; Hickmott JW; Lam SL; Dreolini L; Mathelier A; Baker O; Kuehne C; Bonaguro RJ; Smith J; Tan CV; Zhou M; Goldowitz D; Deussing JM; Stewart AF; Wasserman WW; Holt RA; Simpson EM
Genetics; 2019 Apr; 211(4):1155-1177. PubMed ID: 30765420
[TBL] [Abstract][Full Text] [Related]
27. Temporally controlled somatic mutagenesis in smooth muscle.
Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
[TBL] [Abstract][Full Text] [Related]
28. Specificity and efficiency of reporter expression in adult neural progenitors vary substantially among nestin-CreER(T2) lines.
Sun MY; Yetman MJ; Lee TC; Chen Y; Jankowsky JL
J Comp Neurol; 2014 Apr; 522(5):1191-208. PubMed ID: 24519019
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Analysis of Supporting Cell Subtype Labeling Among CreER Lines in the Neonatal Mouse Cochlea.
McGovern MM; Brancheck J; Grant AC; Graves KA; Cox BC
J Assoc Res Otolaryngol; 2017 Apr; 18(2):227-245. PubMed ID: 27873085
[TBL] [Abstract][Full Text] [Related]
30. A New Autosomal
Deaton RA; Bulut G; Serbulea V; Salamon A; Shankman LS; Nguyen AT; Owens GK
Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):203-211. PubMed ID: 36519470
[TBL] [Abstract][Full Text] [Related]
31. Ligand-Controlled Site-Specific Recombination in Zebrafish.
Chekuru A; Kuscha V; Hans S; Brand M
Methods Mol Biol; 2017; 1642():87-97. PubMed ID: 28815495
[TBL] [Abstract][Full Text] [Related]
32. Pax genes and organogenesis: Pax9 meets tooth development.
Peters H; Neubüser A; Balling R
Eur J Oral Sci; 1998 Jan; 106 Suppl 1():38-43. PubMed ID: 9541201
[TBL] [Abstract][Full Text] [Related]
33. A practical approach to genetic inducible fate mapping: a visual guide to mark and track cells in vivo.
Brown A; Brown S; Ellisor D; Hagan N; Normand E; Zervas M
J Vis Exp; 2009 Dec; (34):. PubMed ID: 20042997
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen modulates apoptosis in multiple modes of action in CreER mice.
Takebayashi H; Usui N; Ono K; Ikenaka K
Genesis; 2008 Dec; 46(12):775-81. PubMed ID: 19105217
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional analysis of the human PAX9 promoter.
Almeida CV; Andrade SC; Saito CP; Ramenzoni LL; Line SR
J Appl Oral Sci; 2010; 18(5):482-6. PubMed ID: 21085804
[TBL] [Abstract][Full Text] [Related]
36. Generation and characterization of Lhx4
Dong X; Xie X; Guo L; Xu J; Xu M; Liang G; Gan L
Genesis; 2019 Oct; 57(10):e23328. PubMed ID: 31313880
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional activity analysis of promoter region of human PAX9 gene under dexamethasone, retinoic acid, and ergocalciferol treatment in MCF-7 and MDPC23.
Ramenzoni LL; Saito CP; McCormick JJ; Line SR
Cell Biochem Funct; 2010 Oct; 28(7):555-64. PubMed ID: 20941745
[TBL] [Abstract][Full Text] [Related]
38. PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer.
Zhao Z; Szczepanski AP; Tsuboyama N; Abdala-Valencia H; Goo YA; Singer BD; Bartom ET; Yue F; Wang L
Cancer Res; 2021 Sep; 81(18):4696-4708. PubMed ID: 34341073
[TBL] [Abstract][Full Text] [Related]
39. Generation of B6-Ddx4
Le HT; Hasegawa Y; Daitoku Y; Kato K; Miznuo-Iijima S; Dinh TTH; Kuba Y; Osawa Y; Mikami N; Morimoto K; Ayabe S; Tanimoto Y; Murata K; Yagami KI; Takahashi S; Mizuno S; Sugiyama F
Genesis; 2020 Jul; 58(7):e23367. PubMed ID: 32293787
[TBL] [Abstract][Full Text] [Related]
40. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
